EUVIMEDEUVIMED entdecken
Open Access

Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma?

Elif Açar, Serpil Köylüce, Serhat Şeker, Hatice Eylül Bozkurt Yilmaz, Elif Aktaş Yapici, Bahar Arslan, Gülden Paçaci Çetin, Murat Türk, İnsu Yilmaz

Tuberk Toraks · 2025

DOI: 10.5578/tt.2025011058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberk Toraks, 2025. Verfasst von Elif Açar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University Faculty of Medicine, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Asthma, Nasal Polyps, Rhinitis. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAsthmaNasal PolypsRhinitisAnti-Asthmatic AgentsEosinophiliaHumansQuality of LifeMaleFemaleMiddle AgedAdultTreatment OutcomeSinusitisSurveys and Questionnaires

Substanzen

mepolizumabAntibodies, Monoclonal, HumanizedAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University Faculty of Medicine, Kayseri, Türkiye.

Zitieren

APA

Açar, E., Köylüce, S., Şeker, S., Bozkurt Yilmaz, H. E., Aktaş Yapici, E., Arslan, B., Paçaci Çetin, G., Türk, M., & Yilmaz, İ. (2025). Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma?. Tuberk Toraks. https://doi.org/10.5578/tt.2025011058

Vancouver

Açar E, Köylüce S, Şeker S, Bozkurt Yilmaz HE, Aktaş Yapici E, Arslan B, et al. Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma?. Tuberk Toraks. 2025. doi:10.5578/tt.2025011058

BibTeX
@article{Aar2025,
  author = {Açar, Elif and Köylüce, Serpil and Şeker, Serhat and Bozkurt Yilmaz, Hatice Eylül and Aktaş Yapici, Elif and Arslan, Bahar and Paçaci Çetin, Gülden and Türk, Murat and Yilmaz, İnsu},
  title = {Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma?},
  journal = {Tuberk Toraks},
  year = {2025},
  doi = {10.5578/tt.2025011058}
}
Kostenlos starten →